References
- Raza A., Alvi S., Broady‐Robinson L., Showel M., Cartlidge J., Mundle S. D., Shetty V., Borok R. Z., Dar S. E., Chopra H. K., Span L., Parcharidou A., Hines C., Gezer S., Venugopal P., Loew J., Showel J., Alston D., Hernandez B., Rifkin S., Robin E., Shah R., Gregory S. Cell cycle kinetic studies in 68 patients with myelod‐ysplastic syndromes following intravenous iodo‐and/or bro‐modeoxyuridine. Experimental Hematology 1997; 25: 530–535
- Raza A., Alvi S., Broady‐Robinson L., Showel M., Cartlidge J., Mundle S. D., Shetty V., Borok Z., Dar S. E., Chopra H. K., Span L., Parcharidou A., Hines C., Gezer S., Venugopal P., Loew J., Alston D., Hernandez B., Rifkin S., Robin E., Shah R., Gregory S. Excessive proliferation matched by excessive apoptosis in myelodysplastic syndromes: The cause‐effect relationship. Leukemia and Lymphoma. 1997, In Press
- Raza A., Gezer S., Mundle S., Gao X. ‐Z., Alvi S., Borok R., Rifkin S., Iftikhar A., Shetty V., Parcharidou A., Loew J., Marcus B., Khan Z., Chaney C., Showel J., Gregory S., Preisler H. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 1995; 86(1)268–276
- Raza A., Mundle S., Shetty V., Alvi S., Chopra H., Span L., Parcharidou A., Dar S., Venugopal P., Borok R., Gezer S., Showel J., Loew J., Robin E., Rifkin S., Alston D., Hernandez B., Shah R., Kaizer H., Gregory S. A paradigm shift in myelodysplastic syndromes. Leukemia 1996; 10: 1648–1652
- Raza A., Mundle S., Shetty V., Alvi S., Chopra H., Dar S., Venugopal P., Borok R., Gezer S., Showel J., Robin E., Rifkin S., Alston D., Hernandez B., Gregory S. Novel insights into the biology of Myelodysplastic Syndromes: Excessive apoptosis and the role of cytokines. International Journal of Hematology 1996; 63: 265–278
- Shetty V., Mundle S., Alvi S., Showel M., Broady‐Robinson L., Dar S., Borok R., Showel J., Gregory S., Rifkin S., Gezer S., Parcharidou A., Venugopal P., Shah R., Hernandez B., Klein M., Alston D., Robin E., Dominquez C., Raza A. Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes. Leuk Res 1996; 20(11/12)891–900
- List A. F., Brasfield R., Heaton R., Glinsmann‐Gibson B., Crook L., Taetle R., Capizzi R. Stimulation of hematopoiesis by amifostine in patients with myelodysplastic syndromes. Blood 1997; 90(9)3364–3369
- Raza A., Venugopal P., Gezer S., Gregory S., Dong L. M., Leurgans S., Mundle S. D., Shetty V. T., Alvi S., Ali A., Span L., Dar S. E., Hines C., Hsu W. ‐T., Loew J., Borok R. Z., Hernandez B., Robin E., Rifkin S., Alston D., Shah R., Preisler H. D. Pilot study of pentoxifylline and ciprofloxacin with or without dexamethasone produces encouraging results in myelodysplastic syndromes. Acute Leukemias VII: Experimental Approaches and Novel Therapies, W. Hiddemann, T. Buchner, B. Wormann, J. Rit‐ter, U. Creutzig, M. Keating, W. Plunkett. Springer‐Verlag Berlin Heideberg, New York 1998; 42–51
- Raza A., Qawi H., Andric T., Gezer S., Venugopal P., Gregory S. A., Hines C., Mundle S. D., Ali A., Shetty V., Mativi B., Dar S., Loew J., Robin E. L., Rifkin S. D., Alston D., Hernandez B. M., Shah R. Combination of Pentoxifylline, Ciprofloxacin, Dexamethasone with Amifostine improves ineffective hematopoiesis in 70% patients with myelodysplastic syndromes. Proc Am Soc Hematol, Blood 1997; 90(10)84a, abstr#367
- Bennet J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189–199
- Verhoef G., DeWolf‐Peters C., Kerim S., Van de Broeck J., Mecucci C., Van den Bergh H., Boogaerts M. A. Update on the prognostic implication of morphology, histology and karyotype in primary myelodysplastic syndromes. Hematol Pathol 1991; 5: 163–175
- Hellstrom‐Lindberg E., Kanter‐Lewensohn L., Ost A. Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte‐CSF and erythropoietin. Leuk Res 1997; 21: 415–425
- Rajapaksa R., Ginzton N., Rott L. S., Greenberg P. Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells. Blood 1996; 88: 4275–4287
- Verhoef G. E. G., DeSchouwer P., Ceuppens J. L., Van Damme J., Goossens W., Boogaerts M. A. Measurement of serum cytokine levels in patients with myelodysplastic syndromes. Leukemia 1992; 6(12)1268–1272
- Mundle S., Iftikhar A., Shetty V., Dameron S., Wright‐Quinones V., Marcus B., Loew J., Gregory S., Raza A. Novel in situ double‐labeling for simultaneous detection of proliferation and apoptosis. J Histochem Cytochem 1994; 42(12)1533–1537